These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32323449)

  • 41. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.
    Tramonti G; Kanwar YS
    Endocrine; 2013 Jun; 43(3):494-503. PubMed ID: 23086402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in urine proteome accompanying diabetic nephropathy progression.
    Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
    Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
    Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
    PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.
    Zhu H; Liu M; Yu H; Liu X; Zhong Y; Shu J; Fu X; Cai G; Chen X; Geng W; Yang X; Wu M; Li Z; Zhang D
    J Diabetes Res; 2017; 2017():5728087. PubMed ID: 28401167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
    Kalani A; Mohan A; Godbole MM; Bhatia E; Gupta A; Sharma RK; Tiwari S
    PLoS One; 2013; 8(3):e60177. PubMed ID: 23544132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinico-Pathological Progress in Diabetic Nephropathy].
    Wada T
    Rinsho Byori; 2016 Aug; 64(8):954-959. PubMed ID: 30609338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
    Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
    BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.
    Chen J; Zhang WW; Chen KH; Lin LR; Dai HZ; Li KL; Zhang JG; Zheng LQ; Fu BQ; He YN
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F273-F281. PubMed ID: 28356293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FABP1 and FABP2 as markers of diabetic nephropathy.
    Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
    Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
    [No Abstract]   [Full Text] [Related]  

  • 53. Urinary mitochondrial DNA: A potential early biomarker of diabetic nephropathy.
    Cao H; Wu J; Luo J; Chen X; Yang J; Fang L
    Diabetes Metab Res Rev; 2019 May; 35(4):e3131. PubMed ID: 30677222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary proteomics for early diagnosis in diabetic nephropathy.
    Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
    Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
    Nossier AI; Shehata NI; Morsy SM; Saeed DF; Elsayed NM; Ismail MF; Eissa S
    Anal Biochem; 2020 Nov; 609():113967. PubMed ID: 32950495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?
    Bakker SJ; Gansevoort RT; de Zeeuw D
    Curr Hypertens Rep; 2009 Apr; 11(2):111-7. PubMed ID: 19278600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.
    Kamijo-Ikemori A; Sugaya T; Yasuda T; Kawata T; Ota A; Tatsunami S; Kaise R; Ishimitsu T; Tanaka Y; Kimura K
    Diabetes Care; 2011 Mar; 34(3):691-6. PubMed ID: 21273494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel urinary biomarkers in early diabetic kidney disease.
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Curr Diab Rep; 2014 Aug; 14(8):513. PubMed ID: 24919751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
    Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
    Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.